📋 Treatment Protocol

🎯 Phase 1: Initial Treatment (4 weeks)

Frequency: Weekly IV administration
Dosing: Based on AlF/AlF3 levels
Monitoring: Compound clearance tracking
Assessment: Cognitive function testing

🔄 Phase 2: Maintenance (3-6 months)

Frequency: Monthly treatments
Optimization: Dose adjustment based on response
Tracking: Progress monitoring
Safety: Continuous parameter monitoring

📊 Expected Outcomes

Clearance: >95% in 2-4 weeks
Sustained Effect: 12+ months
Cognitive Improvement: Measured via standardized tests
Quality of Life: Daily activity enhancement

⚠️ Safety Monitoring

Vital Signs: Continuous monitoring
Laboratory Values: Regular testing
Organ Function: Safety assessments
Adverse Events: Real-time tracking

← Back to Research Index